Cellular and Humoral Immune Responses to Vaccination for COVID-19 Are Negatively Impacted by Senescent T Cells: A Case Report
Background: Herein, we aimed to follow up on the cellular and humoral immune responses of a group of individuals who initially received the CoronaVac vaccine, followed by a booster with the Pfizer vaccine. Methods: Blood samples were collected: before and 30 days after the first CoronaVac dose; 30,...
Main Authors: | Eliane Aparecida Rosseto-Welter, Silvia Sanches Rodrigues, Amanda Braga de Figueiredo, Carolina Nunes França, Danielle Bruna Leal Oliveira, André Luis Lacerda Bachi, Jônatas Bussador do Amaral, Ricardo Andreotti Siqueira, Laiz Camerão Bento, Ana Paula da Silva, Nydia Strachman Bacal, Carlos Eduardo dos Santos Ferreira, Cristóvão Luis Pitangueira Mangueira, João Renato Rebello Pinho |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/4/840 |
Similar Items
-
Frequency And Factors Associated With Adverse Reactions After Administration of Inactivated COVID-19 Vaccine Among Health Workers
by: Beray Gelmez Taş, et al.
Published: (2023-09-01) -
Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents
by: Daniel Leung, et al.
Published: (2023-03-01) -
Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study
by: Thiago Cerqueira-Silva, et al.
Published: (2022-02-01) -
The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVac
by: Ho-Yu Ng, et al.
Published: (2024-02-01) -
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial
by: Mine Durusu Tanriover, et al.
Published: (2022-11-01)